Evidence map›Paper›PMID 38058630›Full record

ReviewHeliyon2023

A review of the research progress on

Ting Zou, Jing Wang, Xu Wu, Kai Yang, Qiao Zhang, Changli Wang, Xiao Wang, Chongbo Zhao

Abstract readReview
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Shengjiang Xiexin decoction combined with vancomycin forFrontiers in cellular and infection microbiology · 2025
    Article
  14. Article
  15. Article
  16. Phylogeography of a herbalEcology and evolution · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ting ZouCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Jing WangCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Xu WuCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Kai YangCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Qiao ZhangCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Changli WangCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Xiao WangCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Chongbo ZhaoCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethnopharmacological relevance: Aim of the study: This review aims to provide useful information on the botany, traditional uses, phytochemistry, pharmacology, toxicity and quality control of Materials and methods: Data was obtained through a systematic search of published literature and online databases such as Google Scholar, Web of Science, PubMed, Science Direct, and Sci-Finder. The botanical names were confirmed using the World Flora Online and chemical structures were drawn using the ChemBio Draw Ultra Version 19.0 Software. Results: Conclusions:

Indexed as

BotanyPharmacologyPhytochemistryPinellia ternata (Thunb.) breitQuality controlToxicityTraditional uses

Identifiers

PMID38058630
PMCPMC10696046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.